Search
for
Sort by
Research 211–240 of 1000+
- Current evaluation of amenorrhea
- Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Sex hormone–binding globulin and risk of hyperglycemia in patients with androgenetic alopecia
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study
- Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review
- Metabolic Syndrome Prevalence in Psoriasis
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Enzymology of the hair follicle.
- Scientific opinion on the tolerable upper intake level for selenium
- Acanthosis nigricans and the metabolic syndrome
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
- Insulin resistance and the long-term consequences of polycystic ovary syndrome
- Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study
- Managing Polycystic Ovary Syndrome: A Cognitive Behavioral Strategy
- Obesity and the Polycystic Ovary Syndrome
- Current understanding of androgenetic alopecia. Part I: etiopathogenesis.
- Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management
- Polycystic ovary syndrome and infertility: an update
- Hepatic Adenoma in an Adolescent With Elevated Androgen Levels
- Association of Insulin Resistance with Hyperandrogenia in Women
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Dihydrotestosteron und die Rolle der 5α-Reduktasehemmer bei der benignen Prostatahyperplasie
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Polycystic Ovary Syndrome (PCOS) and Fertility
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase